Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024
资讯
2024-09-18
Late-breaking presentations will reveal important new data from the phase III OLYMPIA and ARCADIA trials, including durability and long-term efficacy of nemolizumab in prurigo nodularis and atopic d...